Logo Eclevar

LSI Europe: A reflection on routes to market.

Summary of the MDCG Guidance Document MDCG 2019-9 Rev.1 SSCP Summary of safety and clinical performance.

LSI Europe: A reflection on routes to market. 

Eclevar Medtech was proud to sponsor LSI’s hugely successful event in London. It was an opportunity to meet and connect with a wide range of innovators, investors and key experts in the field.

We were able to host 2 panels, the first being on Route to Market for medical devices. An interesting session offering a high- level look at the key checkpoints on the journey to market access.

Some of the questions asked during and following the session were – where do I start with classification? What’s different under the EU MDR?

Determining the correct classification is KEY! It dictates your next steps and requirements in bringing a product to market.

Medical device classification is based on the devices intended use, characteristics and its inherent risks.

THE CATEGORIES:

Class I

  • Class I
  • Class Is
  • Class Im – measuring function 
  • Class Ir – reusable Ir – reusable surgical instrument 

Class IIa

Class IIb

  • Class IIb
  • Class IIb implantable

Class III

The classification rules sit in Annex VIII of Regulation 2017/745 

Under the new regulations we see an increase in the rules compared to the MDD 9/42/EEC – there are 22 classification rules split in to 4 groups:

  • Non-invasive medical devices (Rules 1-4)
  • Invasive medical devices (Rules 5-8)
  • Active medical devices (Rules 9-13)
  • Special rules (Rules 14-22)

How to determine a classification

There is additional support in MDCG 2021-24 – Guidance on classification of medical devices

It is critical to have a clear understanding of the device and the following aspects:

  • Specific medical purpose
  • Duration of use: is it transient, short term or long term?
  • Is the device invasive?
  • Is it an active medical device?
  • Does is have a measuring function?
  • Do you have a system or procedure pack?

 

It is the intended use of a device that determines the classification – not any ‘off-label’ use that may occur.

The rules should be considered in order to establish the proper classification, it is very possible that more than one rule will apply. For example, an active medical device may also have general rules that also apply.

Where a device is covered by more than one rule it is the strictest rule or sub- rule that gives the highest classification that is applicable.

If you are unsure, seek support – for formal determination Competent Authorities can be approached. Note some charge for this service!

 

Here are the rules!

LSI Europe A reflection on routes to market eclevar pmcf study
LSI Europe A reflection on routes to market pmcf medical devices cro
LSI Europe A reflection on routes to market pmcf usa eclevar
LSI Europe A reflection on routes to market pmcf australia eclevar
LSI Europe A reflection on routes to market eclevar pmcf medical cro
LSI Europe A reflection on routes to market eclevar pmcf surveys
LSI Europe A reflection on routes to market eclevar pmcf plan
LSI Europe A reflection on routes to market eclevar
LSI Europe A reflection on routes to market uk
LSI Europe A reflection on routes to market pmcf
LSI Europe A reflection on routes to market

We hope this has been a useful guide on where to start with your classification, if you have further questions, please do review MDCG 2021-24, it also contains key definitions and the implications of the classification.